Beijing Business Daily Message (Reporter Ding Ning) On the evening of June 13, China Resources Shuanghe (600062) announced that Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, had received the Drug Registration Certificate of Low Calcium Peritoneal Dialysate (Lactate-G1.5%), Low Calcium Peritoneal Dialysate (Lactate-G2.5%), Low Calcium Peritoneal Dialysate (Lactate-G4.25%) issued by the State Drug Administration.
The announcement shows that low calcium peritoneal dialysate (lactate) series products are mainly applicable to patients with acute and chronic renal failure who need continuous ambulatory peritoneal dialysis because non dialysis treatment is ineffective.